Cargando…

Malignant germ cell tumours of the testis express interferon-γ, but are resistant to endogenous interferon-γ

Cytokines possess discrepant effects on tumour cells varying from anti- to proapoptotic activities. We recently reported that testicular germ cell tumours (TGCT) express a functional form of the proinflammatory cytokine interferon-gamma (IFNγ). The present study asked whether TGCT-derived IFNγ influ...

Descripción completa

Detalles Bibliográficos
Autores principales: Schweyer, S, Soruri, A, Peters, J, Wagner, A, Radzun, H J, Fayyazi, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394488/
https://www.ncbi.nlm.nih.gov/pubmed/12942126
http://dx.doi.org/10.1038/sj.bjc.6601209
_version_ 1782155428131504128
author Schweyer, S
Soruri, A
Peters, J
Wagner, A
Radzun, H J
Fayyazi, A
author_facet Schweyer, S
Soruri, A
Peters, J
Wagner, A
Radzun, H J
Fayyazi, A
author_sort Schweyer, S
collection PubMed
description Cytokines possess discrepant effects on tumour cells varying from anti- to proapoptotic activities. We recently reported that testicular germ cell tumours (TGCT) express a functional form of the proinflammatory cytokine interferon-gamma (IFNγ). The present study asked whether TGCT-derived IFNγ influences survival or death of neoplastic germ cells. Analysis of TGCT cell lines demonstrated that they expressed and secreted IFNγ, but were resistant to the endogenous IFNγ since neutralisation of IFNγ by a specific blocking antibody had no influence on the proliferation and/or the degree of apoptosis of tumour cells. To study mechanisms providing tumour resistance to endogenous IFNγ, we analysed primary TGCT and two human TGCT cell lines (NTERA and NCCIT) for the expression of IFNγ receptor and for the level of phosphorylation of the signal transducer and activator of transcription (STAT)-1. In situ hybridisation, immunocytochemistry, Western blot analysis and flow cytometry indicated that primary TGCT as well as NCCIT and NTERA cell lines expressed the heterodimeric cell surface IFNγ receptor which consists of both 90-kDa α- and the 85-kDa β-chains. However, the downstream transcription factor STAT-1 was not phosphorylated constitutively, indicating that STAT-1 is not activated by the endogenous IFNγ. Upon application of recombinant human IFNγ in excess, however, STAT-1 was phosphorylated and the interferon regulatory factor-1 (IRF-1) was induced, suggesting that both IFNγR and STAT-1 are functionally intact in TGCT. Altogether our results suggest that despite secreting biologically active IFNγ, the concentration of the endogenous IFNγ is too low to stimulate the IFNγR/STAT signalling pathway in TGCT in an autocrine and/or paracrine manner.
format Text
id pubmed-2394488
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23944882009-09-10 Malignant germ cell tumours of the testis express interferon-γ, but are resistant to endogenous interferon-γ Schweyer, S Soruri, A Peters, J Wagner, A Radzun, H J Fayyazi, A Br J Cancer Experimental Therapeutics Cytokines possess discrepant effects on tumour cells varying from anti- to proapoptotic activities. We recently reported that testicular germ cell tumours (TGCT) express a functional form of the proinflammatory cytokine interferon-gamma (IFNγ). The present study asked whether TGCT-derived IFNγ influences survival or death of neoplastic germ cells. Analysis of TGCT cell lines demonstrated that they expressed and secreted IFNγ, but were resistant to the endogenous IFNγ since neutralisation of IFNγ by a specific blocking antibody had no influence on the proliferation and/or the degree of apoptosis of tumour cells. To study mechanisms providing tumour resistance to endogenous IFNγ, we analysed primary TGCT and two human TGCT cell lines (NTERA and NCCIT) for the expression of IFNγ receptor and for the level of phosphorylation of the signal transducer and activator of transcription (STAT)-1. In situ hybridisation, immunocytochemistry, Western blot analysis and flow cytometry indicated that primary TGCT as well as NCCIT and NTERA cell lines expressed the heterodimeric cell surface IFNγ receptor which consists of both 90-kDa α- and the 85-kDa β-chains. However, the downstream transcription factor STAT-1 was not phosphorylated constitutively, indicating that STAT-1 is not activated by the endogenous IFNγ. Upon application of recombinant human IFNγ in excess, however, STAT-1 was phosphorylated and the interferon regulatory factor-1 (IRF-1) was induced, suggesting that both IFNγR and STAT-1 are functionally intact in TGCT. Altogether our results suggest that despite secreting biologically active IFNγ, the concentration of the endogenous IFNγ is too low to stimulate the IFNγR/STAT signalling pathway in TGCT in an autocrine and/or paracrine manner. Nature Publishing Group 2003-09-01 2003-08-26 /pmc/articles/PMC2394488/ /pubmed/12942126 http://dx.doi.org/10.1038/sj.bjc.6601209 Text en Copyright © 2003 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Experimental Therapeutics
Schweyer, S
Soruri, A
Peters, J
Wagner, A
Radzun, H J
Fayyazi, A
Malignant germ cell tumours of the testis express interferon-γ, but are resistant to endogenous interferon-γ
title Malignant germ cell tumours of the testis express interferon-γ, but are resistant to endogenous interferon-γ
title_full Malignant germ cell tumours of the testis express interferon-γ, but are resistant to endogenous interferon-γ
title_fullStr Malignant germ cell tumours of the testis express interferon-γ, but are resistant to endogenous interferon-γ
title_full_unstemmed Malignant germ cell tumours of the testis express interferon-γ, but are resistant to endogenous interferon-γ
title_short Malignant germ cell tumours of the testis express interferon-γ, but are resistant to endogenous interferon-γ
title_sort malignant germ cell tumours of the testis express interferon-γ, but are resistant to endogenous interferon-γ
topic Experimental Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394488/
https://www.ncbi.nlm.nih.gov/pubmed/12942126
http://dx.doi.org/10.1038/sj.bjc.6601209
work_keys_str_mv AT schweyers malignantgermcelltumoursofthetestisexpressinterferongbutareresistanttoendogenousinterferong
AT soruria malignantgermcelltumoursofthetestisexpressinterferongbutareresistanttoendogenousinterferong
AT petersj malignantgermcelltumoursofthetestisexpressinterferongbutareresistanttoendogenousinterferong
AT wagnera malignantgermcelltumoursofthetestisexpressinterferongbutareresistanttoendogenousinterferong
AT radzunhj malignantgermcelltumoursofthetestisexpressinterferongbutareresistanttoendogenousinterferong
AT fayyazia malignantgermcelltumoursofthetestisexpressinterferongbutareresistanttoendogenousinterferong